Baird analyst Catherine Ramsey Schulte lowered the firm’s price target on Thermo Fisher (TMO) to $622 from $632 and keeps an Outperform rating on the shares. The firm said they reported mixed 3Q results, including revenue slightly below consensus but earnings beat. Management framed market conditions as in-line with expectations, with modest end-market improvements/stability across the portfolio.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TMO:
- Thermo Fisher price target lowered to $610 from $620 at Barclays
- Thermo Fisher Scientific Reports Earnings: Did it Beat Estimate Forecasts?
- Thermo Fisher sees Q4 EPS $5.96, consensus $5.98
- Morning Movers: AT&T rises and Coca-Cola falls following quarterly reports
- Thermo Fisher reports Q3 adjusted EPS $5.28, consensus $5.24